Discovery of LOU064 (remibrutinib), a potent and highly selective covalent inhibitor of Bruton's tyrosine kinase

Angst D, Gessier F, Janser P, Vulpetti A, Wälchli R, Beerli C, Littlewood-Evans A, Dawson J, Nuesslein-Hildesheim B, Wieczorek G, Gutmann S, Scheufler C, Hinniger A, Zimmerlin A, Funhoff EG, Pulz R & Cenni B
Choose the citation style.
Angst, D., Gessier, F., Janser, P., Vulpetti, A., Wälchli, R., Beerli, C., … Cenni, B. (2020). Discovery of LOU064 (remibrutinib), a potent and highly selective covalent inhibitor of Bruton's tyrosine kinase. Journal of Medicinal Chemistry, 63(10), 5102-5118. https://doi.org/10.1021/acs.jmedchem.9b01916